Zobrazeno 1 - 7 of 7 pro vyhledávání: '"József, Erfán"'
2
Capecitabine in Combination with Docetaxel in First Line in HER2-Negative Metastatic Breast Cancer: an Observational Study
Autor: Gábor Pajkos, Zsuzsanna Pápai, Dóra Sántha, Renáta Kószó, Károly Máhr, László Landherr, József Erfán, Zsuzsanna Kahán, Laszlo Budi, Erika Hitre, Judit Kocsis, Zsolt Horváth, Károly Győrfy
Publikováno v: Pathology oncology research : POR. 23(3)
Due to the limited experience with capecitabine plus docetaxel (XT) combination in the first-line treatment of metastatic breast cancer in Hungary, the main objective of the study was to analyze the effectiveness and tolerability of XT therapy. A pro
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a2035c6eca2cc1e4682c906439dcca5
https://pubmed.ncbi.nlm.nih.gov/27771885
Zobrazit plný text záznamu
3
The state of Hungarian radiotherapy
Autor: Judit Olajos, Olga Ésik, József Erfán, Gabor Liposits, Szabolcs Bellyei, Róbert Farkas
Publikováno v: Reports of Practical Oncology & Radiotherapy. 10(4):209-216
Summary Background Hungary suffers from one of the highest levels of cancer morbidity, with over 700 new cases per 100000 inhabitants per year. This situation necessitates, among others, investigation of the current state of radiotherapeutic care, an
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8aa4a597ed016480bdb6733e6894cfb3
Zobrazit plný text záznamu
4
Familial clustering of nasopharyngeal carcinoma in a non-endemic geographical region. Report of two Hungarian cases and a review of the literature
Autor: Yousuf Al-Farhat, Olga Ésik, József Erfán, Erzsébet Füle, László Krenács, Eva Stelkovics, Mónika Francz, Erzsébet Lengyel, Judit Olajos
Publikováno v: Acta Oto-Laryngologica. 125:1008-1013
The aim of this study was to investigate the familial clustering of nasopharyngeal carcinoma (NPC) in a non-endemic geographical region on the basis of two case reports and a review of the literature. Following an upper respiratory infection, NPC (WH
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c21e068488143e4da893a226cdc1ca8
https://doi.org/10.1080/00016480510040155
Zobrazit plný text záznamu
6
[PET scan in patients with epipharyngeal tumors]
Autor: Judit, Olajos, József, Erfán, Zsolt, Lengyel, Miklós, Emri, Erzsébet, Füle, László, Erdélyi, Erzsébet, Lengyel, Olga, Esik, Lajos, Trón
Publikováno v: Orvosi hetilap. 143(21 Suppl 3)
Whole-body FDG PET examinations in 10 cases of epipharyngeal tumour (8 males, 2 females, mean age: 48 years) have been performed since January 1999. The PET examinations were aimed at the accurate staging, follow-up of the patients after the treatmen
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7c9fd0a40e7d9cab9ecc7adcce857306
https://pubmed.ncbi.nlm.nih.gov/12077914
Zobrazit plný text záznamu
7
Efficacy and safety of first-line bevacizumab combined with paclitaxel in 220 patients with metastatic breast cancer: The Hungarian AVAREG observational study
Autor: Béla Pikó, László Mangel, Laszlo Budi, József Erfán, Ágnes Ruzsa, László Landherr, Andras Nagy, Jozsef Cseh, Magdolna Dank
Publikováno v: Journal of Clinical Oncology. 31:e12022-e12022
e12022^ Background: First-line bevacizumab (Bev) combined with paclitaxel (Pac) significantly improves progression-free survival (PFS) and response rate vs. Pac alone in HER2-negative metastatic breast cancer (mBC), as shown in the E2100 study. The e
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5ecee54cb9301be6884e3c49331cb716
https://doi.org/10.1200/jco.2013.31.15_suppl.e12022
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje